Stay updated on Canagliflozin Impact on Heart Failure Clinical Trial
Sign up to get notified when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.

Latest updates to the Canagliflozin Impact on Heart Failure Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedPage history shows the addition of Revision: v3.3.2 and the removal of Revision: v3.2.0; no substantive study content appears to be affected.SummaryDifference0.1%

- Check28 days agoChange DetectedRemoved a government funding/operating status notice from the page; the rest of the study record content remains unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check42 days agoChange DetectedThe new version shows updates to the Study Status and Recruitment Status in the record history, and may include corresponding changes to locations or contacts.SummaryDifference0.1%

- Check71 days agoChange Detected- Added a government funding notice with operational details and links; - Updated version to v3.2.0; - Removed reference to v3.1.0.SummaryDifference11%

- Check78 days agoChange DetectedUpdated version from v3.0.2 to v3.1.0, indicating a new release. No other content changes were detected.SummaryDifference0.3%

- Check92 days agoChange DetectedThe page now displays Revision: v3.0.2, replacing v3.0.1, and the Back to Top element has been removed. This is a minor maintenance update with no impact on core content, pricing, stock, or other critical data.SummaryDifference0.6%

Stay in the know with updates to Canagliflozin Impact on Heart Failure Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Canagliflozin Impact on Heart Failure Clinical Trial page.